feed,title,long_url,short_url
Benzinga,Kodiak's Eye Disease Candidate At Par With Regeneron's Eylea In Visual Acuity Gains,https://benzinga.com/general/biotech/22/08/28393956/kodiaks-eye-disease-candidate-at-par-with-regenerons-eylea-in-visual-acuity-gains,https://bit.ly/3Q9Z2PI
Benzinga,Why Palantir Technologies Stock Is Falling Today,https://benzinga.com/news/earnings/22/08/28395337/why-palantir-technologies-stock-is-falling-today,https://bit.ly/3bGlkcL
Benzinga,$2 Million Bet On This Industrial Stock? 4 Stocks Insiders Are Buying,https://benzinga.com/trading-ideas/long-ideas/22/08/28395714/2-million-bet-on-this-industrial-stock-4-stocks-insiders-are-buying,https://bit.ly/3zxwqJ2
Benzinga,TC BioPharm Says It Aims To Deliver A Big Breakthrough In Cancer Treatments,https://benzinga.com/general/biotech/22/08/28393691/tc-biopharm-says-it-aims-to-deliver-a-big-breakthrough-in-cancer-treatments,https://bit.ly/3JAgFWp
